Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Blockchain Press Releases

Piramal Pharma Limited Announces Consolidated Results for Q1FY24

Published

on

piramal-pharma-limited-announces-consolidated-results-for-q1fy24

MUMBAI, India, Aug. 3, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023.

 

 

Consolidated Financial Highlights

(In INR Crores)

Advertisement

Particulars

Q1

FY24

Q1

FY23

Advertisement

YoY Growth

Q4

FY23

QoQ Growth

Revenue from Operation

Advertisement

1,749

1,482

18 %

2,164

-19 %

Advertisement

   CDMO

898

770

17 %

1,285

Advertisement

-30 %

   Complex Hospital Generic (CHG)

617

508

22 %

Advertisement

702

-12 %

   India Consumer Healthcare (ICH)

239

211

Advertisement

13 %

206

16 %

EBITDA

171

Advertisement

89#

92 %

376

-55 %

EBITDA Margin

Advertisement

10 %

6 %

17 %

PAT

-99

Advertisement

-109

NA

50

-297 %

PAT Margin

Advertisement

-6 %

-7 %

2 %

# Q1 FY23 EBITDA had one-time inventory margin impact of INR 68 Crore

Key Highlights for Q1FY24

Advertisement
  • Revenue from Operation grew by 18% YoY in Q1FY24 driven by broad base performance across all three businesses – CDMO, CHG and ICH
  • EBITDA margin in Q1FY24 was 10%, a YoY improvement compared to 6% in Q1FY23, driven by healthy revenue growth and cost optimization measures 
  • We maintain our quality track record of zero OAIs (Official Action Indicated) as we successfully closed the US FDA inspection at the Pithampur facility with zero observations
  • We strengthened our Management Team by appointing Jeffrey Hampton as President & Chief Operating Officer for Piramal Critical Care (CHG business)
  • We have shared the details of our Rights Issue – Rights Price of INR. 81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46

Nandini Piramal, Chairperson, Piramal Pharma Limited said, “We had a positive start to the new financial year with healthy revenue growth and improvement in our EBITDA margins. Our CDMO business is also witnessing continued order inflows, especially for our differentiated offerings and innovation related work. Our Inhalation Anesthesia portfolio is seeing a healthy demand and our India Consumer Healthcare business is delivering good growth driven by power brands. We continue to maintain our best-in-class quality track record and are also taking multiple initiatives in the area of ESG to grow our business responsibly.
Historically our H2 has been better than H1, both in terms of revenue and profitability. We are working to leverage our good start to the financial year and continuing this momentum to deliver a healthy YoY performance for the rest of the year. We believe in the growth potential of our business and are accordingly executing on our strategic priorities to create shareholder value. Our promoter and promoter group have agreed to subscribe to the extent of 100% of the equity shares offered in our Rights Issue, thereby reaffirming their confidence in the underlying strengths of our business.”

Key Business Highlights for Q1FY24

 

Contract Development and Manufacturing Organization (CDMO):

  • Witnessed continued order inflow momentum and strong execution in Q1FY24. Continue to see good demand for our differentiated offering in the niche areas of high potent API, peptide, anti-body drug conjugate (ADC) and development and manufacturing of on-patent API
  • Recently expanded capacities at sites with differentiated offering witnessing encouraging customer demand
  • Capacity expansion for antibody drug conjugate (ADC) at Grangemouth facility to strengthen our position in the ADC market
  • YoY improvement in demand for our generic API business
  • Maintained our quality track record – Successfully cleared 8 regulatory inspections (including an US FDA inspection at our Pithampur facility) and multiple customer audits in Q1FY24
  • Cost optimization, strategizing procurement and operational excellence initiatives helping to mitigate inflationary pressures and improve profitability

 

Complex Hospital Generics (CHG):

  • Continued momentum in Inhalation Anesthesia (IA) sales, mainly led by strong demand for Sevoflurane
  • Expanding inhalation anesthesia capacity to meet the growing demand
  • Intrathecal portfolio in the US continue to command leading market share
  • Building a pipeline of 27+ new products which are various stages of development. Launched 1 new product during Q1FY24
  • Appointed Jeffrey Hampton as President & Chief Operating Officer of CHG Business. Jeff has previously worked with Accord Healthcare, Inc. and Apotex Inc.  

 

India Consumer Healthcare (ICH):

Advertisement
  • 11 new products and 3 new SKUs launched during Q1FY24
  • Continue to invest in media and trade spends to drive growth in power brands
  • Power Brands – Littles, Lacto Calamine, Polycrol, Tetmosol and I-range, grew by 15% YoY in Q1FY24 and contribute to 43% of ICH sales
  • E-commerce grew by more than 18% YoY in Q1FY24
  • Wide distribution reach across general trade and are also strengthening our presence in alternate channels of distribution including e-commerce, modern trade, and having our own direct-to-customer website -Wellify.in

 

 

Consolidated Profit and Loss Statement

(In INR Crores)

Reported Financials

Particulars

Advertisement

Q1FY24

Q1FY23

YoY  Change

Q4FY22

QoQ  Change

Advertisement

Revenue from Operations

1,749

1,482

18 %

2,164

Advertisement

-19 %

Other Income

38

72

-47 %

Advertisement

25

56 %

Total Income

1,787

1,554

Advertisement

15 %

2,188

-18 %

Material Cost

627

Advertisement

574

9 %

840

-25 %

Employee Expenses

Advertisement

496

461

8 %

474

5 %

Advertisement

Other Expenses

494

430

15 %

499

Advertisement

-1 %

EBITDA

171

89#

92 %

Advertisement

376

-55 %

Finance Cost

119

62

Advertisement

90 %

104

14 %

Depreciation

174

Advertisement

162

7 %

184

-6 %

Share of net profit of associates

Advertisement

14

20

-28 %

8

85 %

Advertisement

Profit Before Tax

-107

-115

-7 %

95

Advertisement

-213 %

Tax

-9

-6

NA

Advertisement

45

-119 %

Net Profit after Tax

-99

-109

Advertisement

NA

50

-297 %

Exceptional item

0

Advertisement

0

0

Net Profit after Tax after exceptional item

-99

-109

Advertisement

NA

50

-297 %

 # Q1 FY23 EBITDA had one-time inventory margin impact of INR 68 Crore

Q1FY24 Earnings Conference Call

Advertisement

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 4th August 2023 at 10:00 AM (IST) to discuss its Q1FY24 Results. 

The dial-in details for the call are as under:

Event

Location & Time

Telephone Number

Advertisement

Conference call on
4th August, 2023

India – 10:00 AM IST

+91 22 6280 1461 / +91 22 7115 8320 (Primary Number)

1 800 120 1221 (Toll free number)

USA – 12:30 AM

Advertisement

(Eastern Time – New York)

Toll free number

18667462133

UK – 5:30 AM

(London Time)

Advertisement

Toll free number

08081011573

Singapore – 12:30 PM

(Singapore Time)

Toll free number

Advertisement

8001012045

Hong Kong – 12:30 PM

(Hong Kong Time)

Toll free number

800964448

Advertisement

Express Join with Diamond Pass™

Please use this link for prior registration to reduce wait time at the time of joining the call –https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9503078&linkSecurityString=33aa158d84

About Piramal Pharma Ltd:

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter products. In addition, one of PPL’s associate companies, Allergan India Private Limited is a JV with AbbVie Inc. and has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.

For more information visit: www.piramaI.com/pharma I I inker1ln | Facebook I Twitter.

Advertisement

Photo: https://mma.prnewswire.com/media/2169456/Nandini_Piramal.jpg
Logo: https://mma.prnewswire.com/media/1855206/4196563/Piramal_Pharma_Limited_Logo.jpg

 

Piramal Pharma Limited Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-limited-announces-consolidated-results-for-q1fy24-301893273.html

Continue Reading
Advertisement

Blockchain Press Releases

Bybit Pledges RMB 5 Million to Support Relief Efforts Following Devastating Tibet Earthquake

Published

on

bybit-pledges-rmb-5-million-to-support-relief-efforts-following-devastating-tibet-earthquake

DUBAI, UAE, Jan. 16, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is deeply saddened by the devastating earthquake that struck Tibet earlier this week, leaving a trail of destruction and heartache.

The tragedy has claimed at least 126 lives, injured 188 people, and displaced tens of thousands as over 3,000 buildings collapsed in the remote region near the northern base of Mount Everest. In response, Bybit is committing RMB 5 million in collaboration with the Red Cross Society of China (RCSC) to support critical relief and recovery efforts in the affected communities.

The 7.1-magnitude earthquake, which struck on January 7, has caused widespread devastation, with extreme winter conditions complicating rescue operations. More than 14,000 rescue workers have been mobilized to search for survivors amid sub-zero temperatures and strong winds, highlighting the urgent need for immediate aid.

“As a responsible global leader in the blockchain industry, Bybit is committed to standing with communities in their time of need,” said Helen Liu, Chief Operating Officer at Bybit. “Our thoughts are with the survivors, the rescue teams, and the families affected by this tragic event. We hope our contribution will help provide much-needed relief and support the road to recovery.”

The donation will be directed towards essential services, including emergency shelter, medical supplies, and food aid, as well as long-term rehabilitation efforts. Bybit is proud to partner with RCSC to ensure swift and impactful assistance to those in need.

Advertisement

At Bybit, we firmly believe in the power of compassion and collaboration. This contribution reflects our commitment to fostering resilience and hope in the face of adversity.

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press 

Advertisement

For media inquiries, please contact: [email protected]

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Bybit Logo

Photo – https://mma.prnewswire.com/media/2600065/Image.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-pledges-rmb-5-million-to-support-relief-efforts-following-devastating-tibet-earthquake-302353395.html

Continue Reading

Blockchain Press Releases

Bybit & SignalPlus Unveil the 100,000 USDC Global Trading Showdown

Published

on

bybit-&-signalplus-unveil-the-100,000-usdc-global-trading-showdown

DUBAI, UAE, Jan. 16, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, and SignalPlus, an innovative social trading platform aimed at democratizing options trading for digital and crypto assets, are excited to announce the Bybit x SignalPlus 2025 Global Trading Competition. With a staggering total prize pool of 100,000 USDC, this competition promises to be the ultimate stage for traders to showcase their skills and seize lucrative rewards.

From now until February 5, 2025, 8:00 AM UTC, the competition is open to all Bybit users—excluding residents of restricted jurisdictions.. This event invites participants to engage in options, spot, or futures trading for their chance to claim a share of the impressive prize pool.

“We are thrilled to partner with SignalPlus for the Bybit x SignalPlus 2025 Global Trading Competition,” said Joan Han, Sales & Marketing Director at Bybit. “This event reflects our commitment to fostering an active and vibrant trading community. Whether you’re a novice or a seasoned trader, this competition offers a platform to enhance your trading skills and earn exciting rewards.”

Chris Yu, CEO at SignalPlus, shared his enthusiasm: “Collaborating with Bybit reflects our unwavering commitment to empowering traders with cutting-edge tools and actionable insights. This competition is a unique opportunity for participants to showcase their trading expertise and be handsomely rewarded for their achievements.”

Competition Highlights

Advertisement
  • 100,000 USDC Prize Pool: Compete for your share of a massive prize pool.
  • Daily Rewards System: Win prizes daily, with rewards credited promptly to energize your next trades.
  • Team Competition: The top four (4) teams will split a 7,300 USDC prize pool. Daily, one lucky team member will win a luxury 3-day, 2-night trip to Korea or its equivalent value in USDC.
  • Individual Competition: The top 35 winners will share 7,702 USDC, with individual prizes ranging from 30 USDC to 2,000 USDC. Daily rankings and lucky draws offer opportunities to win up to 250 USDC.
  • Daily Lucky Draw: Over 21 days, 129 winners will be chosen daily, ensuring that every trade counts toward exciting rewards.
  • Special Bonuses: Link your Bybit API to SignalPlus for a 10 USDC rebate. Complete your first Options trade on SignalPlus to earn an additional 20 USDC rebate.

For more details on the Bybit x SignalPlus 2025 Global Trading Competition, please visit here: https://announcements.bybit.com/article/-bybit-x-signalplus-2025-global-trading-competition-returns-with-bigger-rewards-win-your-share-of-the-100-000-usdc-prize-pool–blt36f0435aff9e950f/

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: [email protected]
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Advertisement

Photo – https://mma.prnewswire.com/media/2599537/Bybit___SignalPlus_Unveil_100_000_USDC_Global_Trading_Showdown.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit–signalplus-unveil-the-100-000-usdc-global-trading-showdown-302352908.html

Continue Reading

Blockchain

Blocks & Headlines: Today in Blockchain (BubbleMaps, Pantera Capital, Week 2025, FP Complete, FP Block, Bybit, FarmX)

Published

on

blocks-&-headlines:-today-in-blockchain-(bubblemaps,-pantera-capital,-week-2025,-fp-complete,-fp-block,-bybit,-farmx)

 

Op-Ed: Blockchain’s Expanding Horizons

Blockchain technology continues to disrupt traditional systems, fostering innovation across diverse industries. From advancing digital infrastructure to enhancing transparency and security, its transformative potential is undeniable. Today’s briefing delves into groundbreaking developments that underline blockchain’s growing influence globally.


BubbleMaps Enhances Transparency in Solana Ecosystem

BubbleMaps, a blockchain investigation platform, has extended its capabilities to include Solana tokens. This platform empowers users to visualize token distributions, enhancing transparency and accountability within decentralized ecosystems. By highlighting token relationships, BubbleMaps aids in identifying potential risks, such as centralized holdings or suspicious activity.

This expansion underscores the increasing demand for tools that ensure trust and integrity in blockchain networks, a critical factor in driving mass adoption.

Advertisement

Source: Decrypt


Pantera Capital Highlights Blockchain’s Role in USD Dominance

Pantera Capital has published insights emphasizing blockchain’s crucial role in fortifying the U.S. dollar’s global supremacy. By creating robust digital infrastructures, blockchain technologies enable seamless cross-border transactions, enhance financial transparency, and reduce reliance on intermediaries.

The report advocates for strategic adoption of blockchain solutions to maintain the dollar’s position in an increasingly digital financial landscape. This perspective aligns with broader trends favoring blockchain’s integration into national economic strategies.

Source: Daily Hodl


German Blockchain Week 2025: Bridging Europe and Asia

The recently concluded German Blockchain Week 2025 showcased innovative projects and fostered collaboration between European and Asian markets. Key discussions revolved around regulatory harmonization, decentralized finance (DeFi) opportunities, and cross-border partnerships.

Advertisement

This event highlights the importance of international cooperation in addressing challenges and unlocking the full potential of blockchain technology on a global scale.

Source: AccessWire


FP Complete Evolves into FP Block, Emphasizing Blockchain Engineering

FP Complete has announced its strategic transformation into FP Block, marking a significant shift toward blockchain engineering. This rebranding reflects the company’s commitment to delivering cutting-edge blockchain solutions, including smart contract development, decentralized application (dApp) frameworks, and tokenomics design.

The move positions FP Block as a key player in the blockchain innovation space, catering to the growing demand for specialized engineering expertise in decentralized technologies.

Source: Business Wire

Advertisement

Bybit Web3 Launches FarmX on Telegram

Bybit Web3 has unveiled FarmX, a decentralized farming game integrated into Telegram’s Web3 ecosystem. FarmX combines gaming with blockchain-based rewards, enabling players to earn digital assets through in-game activities.

This innovative approach to gaming exemplifies the potential of blockchain to redefine user engagement, blending entertainment with financial incentives in decentralized environments.

Source: PR Newswire


Analysis and Takeaways

  1. Enhanced Transparency: BubbleMaps’ integration of Solana tokens demonstrates the importance of tools that promote transparency in blockchain networks.
  2. Strategic Infrastructure: Pantera Capital’s insights reinforce the critical role of blockchain in maintaining economic dominance in the digital age.
  3. Global Collaboration: Events like German Blockchain Week 2025 emphasize the need for international partnerships to address regulatory and operational challenges.
  4. Specialized Engineering: FP Block’s focus on blockchain engineering highlights the growing demand for expertise in building decentralized systems.
  5. Blockchain Gaming: Bybit Web3’s FarmX showcases the fusion of gaming and blockchain, paving the way for innovative user experiences and financial inclusivity.

 

The post Blocks & Headlines: Today in Blockchain (BubbleMaps, Pantera Capital, Week 2025, FP Complete, FP Block, Bybit, FarmX) appeared first on News, Events, Advertising Options.

Advertisement
Continue Reading
Advertisement
 title=
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE